2023
DOI: 10.1007/s00210-023-02431-7
|View full text |Cite|
|
Sign up to set email alerts
|

RETRACTED ARTICLE: Efficient chemosensitizing and antimetastatic combinations of a naturally occurring trans-ferulic acid with different chemotherapies on an in vitro hepatocellular carcinoma model

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 32 publications
0
1
0
Order By: Relevance
“…However, it should be noted that the inhibitory effects of the combined doxorubicin-barakol on MMP-3 activity and cell migration were not investigated in this work and should be further studied. The previous study reported that doxorubicin inhibited hepatic cancer cell (HepG2) migration by suppressing MMP-3 expression, and the inhibition was synergized by co-treatment with a natural-derived compound, trans -ferulic acid [ 66 ]. From this evidence, it is hypothesized that barakol, as an MMP-3 inhibitor, may potentiate the anti-metastatic effect of doxorubicin similarly.…”
Section: Discussionmentioning
confidence: 99%
“…However, it should be noted that the inhibitory effects of the combined doxorubicin-barakol on MMP-3 activity and cell migration were not investigated in this work and should be further studied. The previous study reported that doxorubicin inhibited hepatic cancer cell (HepG2) migration by suppressing MMP-3 expression, and the inhibition was synergized by co-treatment with a natural-derived compound, trans -ferulic acid [ 66 ]. From this evidence, it is hypothesized that barakol, as an MMP-3 inhibitor, may potentiate the anti-metastatic effect of doxorubicin similarly.…”
Section: Discussionmentioning
confidence: 99%